the government allowed russian companies to use the patent of the danish company nova nordisk withoutes geropharm and promomet will be able to produce analogues of the foreign drug azempic, which is used in the treatment of diabetes and which has recently become much more popular as a means of combating excess weight. true, its widespread use raises questions among many doctors. patent for the active substance of this drug, simoglutit belongs. but last year the danish company announced that it was going to stop supplying azempic to russia in december 2023. now the government indicates that it allowed russian companies to use the nova nordisk patent without its consent, a quote due to the urgent need to protect the life and health of citizens . dima, that's all for me. thank you, marina pimenova with business news. the past year has become a milestone in russian relations. finland, moreover, double exactly 100 years ago , diplomatic relations were established between the ussr and finland, in this twenty-third helsinki , took a number of steps at once that call into question the histori